4//SEC Filing
KING THOMAS BRAXTON 4
Accession 0001213900-23-096082
CIK 0001733413other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 4:08 PM ET
Size
5.3 KB
Accession
0001213900-23-096082
Insider Transaction Report
Form 4
KING THOMAS BRAXTON
Director
Transactions
- Award
Stock Options (Right to Buy)
2023-12-13+132,442→ 132,442 totalExercise: $0.35From: 2024-12-13Exp: 2033-12-13→ Common Stock (132,442 underlying)
Footnotes (1)
- [F1]The options vest and first become exercisable in 36 equal monthly installments, with the first installment vesting on December 13, 2024 and the remaining installments on the 13th of the month for the next 35 months.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001279309
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 4:08 PM ET
- Size
- 5.3 KB